How the drive to try something new led to the development of lentiviral vectors for gene therapy.

Cardinal Health’s Fran Gregory looks at innovative payment models for cell and gene therapies.

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.

Have you noticed a shortage of skilled individuals entering the pharma industry?

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

The US Inflation Reduction Act continues to generate controversy as drugmakers make counteroffers.

How a study involving Super Mario Odyssey and depression captured imaginations.

Meet Brad Hocking – a final year PhD student at Imperial College London who is passionate about small molecule drug discovery.

We speak with Vertex Pharmaceuticals about internships and co-ops in the industry for young talent.